prima biomed
Prima BioMed Announces Japanese Collaboration
Prima BioMed and Japanese partners NEC and Yamaguchi University are investigating the use of an adjuvant for a potential liver cancer vaccine.
Prima BioMed and Japanese partners NEC and Yamaguchi University are investigating the use of an adjuvant for a potential liver cancer vaccine.
